TTrialPathMatch Me to Trials
← Back to trials
RecruitingSystolic Blood PressureBlood PressureDepression - Major Depressive Disorder

IMST for Dementia Risk Reduction

Eligible age

60–80 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST) as a non-pharmacologic intervention to reduce cardiovascular and cognitive risks in older adults. Next, investigators will examine secondary effects of IMST on mood, sleep quality, systemic inflammation, and physical/motor function. Finally, investigators will assess participant adherence and acceptability ratings of using an 8-week home-based IMST protocol in a diverse older adult sample.

Sponsor: Florida State University

You may qualify if…

  • Ages 60-80
  • Converted telephone MoCA total score≥18
  • Presence of at least one dementia risk factor (e.g., MCI or subjective cognitive decline, hypertension \[SBP \>130 mmHg or on medication\], sedentary lifestyle \[\<150 min/week\], family history of dementia or self-reported APOE ε4 carrier, or mild sleep-disordered breathing; CAIDE total score \[\>5\]
  • Capable of independently completing or requiring minimal assistance with inspiratory muscle strength training (IMST)
  • Willing to adhere to the IMST protocol (approximately 5-10 minutes per day for 8 weeks)
  • Optional inclusion of inspiratory muscle weakness (MIP \<80 cmH₂O for men, \<70 cmH₂O for women) will also be assessed.

You may not qualify if…

  • tMoCA \<18, or diagnosis of neurodegenerative illness at the discretion of principal investigator (except MCI)
  • Current evidence of any major psychiatric disorder including psychosis (at the discretion of principal investigator), bipolar disorder, severe major depression (PHQ-9 \> 20)
  • Unstable cardiovascular or pulmonary disease
  • Recent respiratory therapy or major medication changes
  • Self-reported severe untreated or unstable obstructive sleep apnea (OSA)
  • Recent start (within the past month) of CPAP or BiPAP, or recent use of inspiratory muscle training
  • Lung and eardrum injuries
  • Non-English speaking

Where it's recruiting

Florida

Tallahassee

Source: ClinicalTrials.gov · NCT07349706 · last updated 2026-03-27